Knockout of NRF2 triggers prostate cancer cells death through ROS modulation and sensitizes to cisplatin

Author(s):Show less -

Mancini, Mariana C. S. ; Morelli, Ana P. ; Severino, Matheus B. ; Pavan, Isadora C. B. ; Zambalde, Erika P. ; Gois, Mariana M. ; da Silva, Luiz G. S. ; Quintero-Ruiz, Nathalia ; Romeiro, Caio F. ; dos Santos Jr, Daniel F. G. ; Bezerra, Rosangela M. N. ; Simabuco, Fernando M.

• Document type: Journal article
• Source: Journal of Cellular Biochemistry; v. 123, n. 12, p. 14-pg., 2022-10-03.

Abstract

Prostate cancer (PCa) represents the second most common cancer in men and affects millions worldwide. Chemotherapy is a common treatment for PCa but the development of resistance is often a problem during therapy. NRF2 (nuclear factor erythroid 2-related factor 2) is one of the major transcription factors regulating antioxidant enzymes and is also involved with drug efflux and detoxification. Cancer cells submitted to chemotherapy often promote NRF2 activation to benefit themselves with the cytoprotective response. Here, we found that DU145 and PC3 PCa cell lines have different responses regarding NRF2 activation, when subjected to arsenite-induced stress, even in the presence of MG132, a proteasome inhibitor. We also observed that only in PC3 cells treated with arsenite, NRF2 was able to translocate to the nucleus. To better understand the role of NRF2 in promoting chemoresistance, we performed CRISPR knockout of NRF2 (NKO) in DU145 and PC3 cells. The effectiveness of the knockout was confirmed through the downregulation of NRF2 targets (p < 0.0001). PC3 NKO cells exhibited higher levels of reactive oxygen species (ROS) compared to wild-type cells (p < 0.0001), while this alteration was not observed in DU145 NKO cells. Despite no modulation in ROS content, a lower IC50 value (p < 0.05) for cisplatin was observed in DU145 NKO cells, suggesting that the knockout sensitized the cells to the treatment. Besides, the treatment of DU145 NKO with cisplatin led cells to apoptosis as observed by the increased levels of PARP1 cleavage (p < 0.05), possibly triggered by increased DNA damage. Reduced levels of KU70 and phospho-CHK2 (p < 0.05) were also detected. The data presented here support that NRF2 is a mediator of oncogenesis and could be a potential target to sensitize PCa cells to chemotherapy, reinforcing the importance of knowing the specific genetic and biochemical characteristics of the cancer cells for a more effective approach against cancer. (AU)

• FAPESP's process: 20/09310-6 - Characterization of the cell interactome of proteins E, M and N of the new Coronavirus of 2019 (SARS-CoV-2)
• Grantee: Érika Pereira Zambalde
• Support Opportunities: Scholarships in Brazil - Post-Doctoral
• FAPESP's process: 20/09133-7 - Genome wide analysis of cisplatin resistance associated genes in A549 Lung Cancer cells using a CRISPR/Cas9 library
• Grantee: Nathalia Quintero Ruiz
• Support Opportunities: Scholarships in Brazil - Post-Doctoral
• FAPESP's process: 16/06457-0 - Leaves and stalks of beet (Beta vulgaris L.): characterization and effects of the antioxidant capacity in obese and dyslipidemic
• Grantee: Rosângela Maria Neves Bezerra
• Support Opportunities: Regular Research Grants
• FAPESP's process: 20/13660-2 - Genome editing of LKB1 gene by CRISPR/Cas9 in lung cancer cells and evaluation of its role in metformin and cisplatin response
• Grantee: Matheus Brandemarte Severino
• Support Opportunities: Scholarships in Brazil - Master
• FAPESP's process: 20/09527-5 - SARS-CoV-2 Nsp9 protein in oxidative stress: nutraceuticals as a therapeutic approach
• Grantee: Luiz Guilherme Salvino da Silva
• Support Opportunities: Scholarships in Brazil - Doctorate
• FAPESP's process: 15/00311-1 - Functional characterization of interacting proteins of different S6Ks isoforms
• Grantee: Isadora Carolina Betim Pavan
• Support Opportunities: Scholarships in Brazil - Master
• FAPESP's process: 20/08684-0 - Study of the interaction between PARP1 and S6K2 and its relation with Cancer metabolism and DNA repair
• Grantee: Mariana Marcela Góis
• Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
• FAPESP's process: 18/14818-9 - Study of molecular targets important for the control of cancer metabolism: the mTOR/S6K pathway as a central role
• Grantee: Fernando Moreira Simabuco
• Support Opportunities: Research Grants - Young Investigators Grants - Phase 2
• FAPESP's process: 19/00607-9 - Characterization of molecular targets involved in chemotherapeutic resistance and tumor metabolism of lung cancer cells
• Grantee: Ana Paula Morelli
• Support Opportunities: Scholarships in Brazil - Master
• FAPESP's process: 19/25582-9 - Study of the role of Nrf2 protein in metabolism regulation and redox control in response to natural food-derived compounds in Prostate Cancer cells
• Grantee: Mariana Camargo Silva Mancini
• Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
• FAPESP's process: 19/25731-4 - Characterization of the soluble isoform of FAS protein (CD95) on cisplatin and apoptosis resistance in lung cancer cells using CRISPR technology
• Grantee: Daniel Francisco Guimarães dos Santos Junior
• Support Opportunities: Scholarships in Brazil - Scientific Initiation